The Journal of Medical Microbiology, Vol 47, Issue 9 837-842, Copyright © 1998 by Society for General Microbiology

JOURNAL ARTICLE

Synergic antistaphylococcal properties of lactoferrin and lysozyme

E. C. Leitch and M. D. Willcox
Cooperative Research Centre for Eye Research and Technology, University of New South Wales, Randwick, Australia.

Staphylococcus epidermidis colonises a wide range of implanted prosthetic devices, but rarely contact lenses -- despite a similarity in material composition. A conceivable explanation for this anomaly is the action of the tear defences, including the constitutive proteins lactoferrin and lysozyme. Therefore this study investigated the effect of lactoferrin, lysozyme and serum on the growth of S. epidermidis isolates in artificial tear fluid. Whether supplemented with serum alone or serum with either apolactoferrin or lysozyme, this medium induced a similar, strain-variable effect. However, simultaneous addition of these proteins induced a greater bactericidal or bacteristatic effect. Of those strains killed by the concerted action of apolactoferrin and lysozyme, the absence of serum led to a further increase in the bactericidal effect, whereas strains displaying bacteriostasis were unaffected by serum. Iron saturation of lactoferrin reversed the antimicrobial synergy of apolactoferrin and lysozyme. These results show synergy between lactoferrin and lysozyme which is dependent on the iron limitation of lactoferrin. As a bactericidal mechanism, this synergy is augmented by serum, but bacteriostasis remains unaffected by serum supplemention. Thus, the combination of lysozyme and lactoferrin may partly explain the low level of contact lens colonisation by S. epidermidis in vivo.

This article has been cited by other articles:

				R. S. McIntosh, J. E. Cade, M. Al-Abed, V. Shanmuganathan, R. Gupta, A. Bhan, P. J. Tighe, and H. S. Dua The Spectrum of Antimicrobial Peptide Expression at the Ocular Surface Invest. Ophthalmol. Vis. Sci., April 1, 2005; 46(4): 1379 - 1385. [Abstract] [Full Text] [PDF]

				O. Levy Antimicrobial proteins and peptides: anti-infective molecules of mammalian leukocytes J. Leukoc. Biol., November 1, 2004; 76(5): 909 - 925. [Abstract] [Full Text] [PDF]

				M. Shaper, S. K. Hollingshead, W. H. Benjamin Jr., and D. E. Briles PspA Protects Streptococcus pneumoniae from Killing by Apolactoferrin, and Antibody to PspA Enhances Killing of Pneumococci by Apolactoferrin Infect. Immun., September 1, 2004; 72(9): 5031 - 5040. [Abstract] [Full Text] [PDF]

				D. Caccavo, N. M. Pellegrino, M. Altamura, A. Rigon, L. Amati, A. Amoroso, and E. Jirillo Review: Antimicrobial and immunoregulatory functions of lactoferrin and its potential therapeutic application Innate Immunity, December 1, 2002; 8(6): 403 - 417. [Abstract] [PDF]

				O. Levy Antimicrobial proteins and peptides of blood: templates for novel antimicrobial agents Blood, October 15, 2000; 96(8): 2664 - 2672. [Abstract] [Full Text] [PDF]